reduce basal insulin dose when starting glp-1 receptor agonist Combination of and agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes? | Diabetology & Metabolic Syndrome Insulin Initiation and Titration in
Description
Personalized Treatment Options Available At Cape Fear Physical Medicine.
Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.
Retatrutide works by activating GLP-1, GIP and glucagon receptors
Looking for the best laxative for GLP-1 constipation
Sarah Mess.
Regarding renal effects, the evidence of SGLT2is in preventing kidney failure is more abundant than for GLP-1RAs, which showed a beneficial effect on albuminuria but not on hard kidney endpoints
